Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic shock

doi:10.4240/wjgs.v11.i12.422

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8072)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

549

WORD

258

HTML

4442

Figures (1-3)

312

Tables (1-4)

311

Sum=5872

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

957

Download

1243

Sum=2200

Dec 27, 2019 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Surg. Dec 27, 2019; 11(12): 422-432
Published online Dec 27, 2019. doi: 10.4240/wjgs.v11.i12.422

Full Size Figure Download Figure

Figure 1 Design of the study protocol from the operation until second session of polymyxin B hemoperfusion. PMX-HP: Polymyxin B hemoperfusion.

Citation: Kim JJ, Park YJ, Moon KY, Park JH, Jeong YK, Kim EY. Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic shock. World J Gastrointest Surg 2019; 11(12): 422-432
URL: https://www.wjgnet.com/1948-9366/full/v11/i12/422.htm
DOI: https://dx.doi.org/10.4240/wjgs.v11.i12.422